Lung cancer has the highest incidence rate among malignant tumors in China, and its mortality rate is also very high. The treatment and full-process management of lung cancer have become the focus of attention. To further promote the development of the discipline of lung cancer diagnosis and treatment, better advance the precise diagnosis, standardized treatment and improve the quality of life of lung cancer patients, the Chengdu High-tech Medical Association held the "MDT Academic Symposium on Non-Small Cell Lung Cancer" on December 31, 2024. All are mainly composed of multi-disciplinary medical and health professionals from oncology, respiratory medicine, thoracic surgery, radiotherapy, pathology and radiology. Centering on the themes of standardized diagnosis and treatment of lung cancer, management of adverse reactions and the latest progress in lung cancer treatment, they aim to enhance the multi-disciplinary diagnosis and treatment level in the field of lung cancer treatment through online communication and learning. This series of conferences aims to build a high-end academic exchange platform, promote the development of related health care undertakings, and facilitate academic exchanges, disciplinary integration, as well as the transformation between academia and industry